In addition, the known oncogenes FLT3, HDAC6, NPM1, and BTK were significantly hypomethylated in EBV(+) DLBCL, suggesting activation [49,50,51,52,53,54,55]. The gene discussed is FLT3; the disease is diffuse large B-cell lymphoma.